my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Qui more
Better than any other development resource, Quintiles answers R&D risk with R&D solutions. These solutions are delivered by highly responsive teams of focused professionals building a customized package of services based on your needs. From early development through late-phase trials, Quintiles of more
Quintiles Austria has been in operation since 1996, providing expert clinical services and innovative solutions for our customers. Our office houses highly trained clinical monitors and project managers. Quintiles Austria offers our experience to pharmaceutical companies around the globe. Key Servic more
Kareus Therapeutics SA, a company focused on the development of novel therapeutics to address high unmet medical need, announced a broad strategic alliance with Quintiles to progress the development of two of Kareus’ pre-clinical programs through clinical trials.Under the terms of the alliance, Quin more
Quintiles and London Genetics announced a strategic alliance to offer the biopharmaceutical industry pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed. Under the non-exclusive alliance, Quintiles and London Genetics will collaborate to help biopharma co more
TranScrip Partners LLP announced the appointment of two new senior partners, Julia Lloyd-Parks and Mark Watling. The move is set to further enhance the organisation’s high level expertise in clinical research, clinical development and medical affairs across multiple therapeutic areas. This latest more
New pharmaceutical strategies pursue increased Research and Development (R&D) investments ranging 15-20% in contrast to late 80's period where classical model across was 10%. The annual budget allocation spent with clinical research organizations (CRO) is approximately $12 billion in an attempt to increase throughput, which has predominantly benefited CRO's who have seen their turnover boost growth of 20-30% year on year. more
by Wan C. Tan, Jean Bourbeau, Paul Hernandez, Kenneth R. Chapman, Robert Cowie, J. Mark FitzGerald, Shawn Aaron, Darcy D. Marciniuk, Francois Maltais, A. Sonia Buist, Denis E. O’Donnell, Don D. Sin Background The relationship between patient-reported symptoms and objective measures of lung functi more
Abstract High IgG titers against the Epstein–Barr virus nuclear antigen, EBNA‐1, have been strongly correlated with the risk of developing multiple sclerosis. ELISAs are used frequently to measure EBNA‐1 titers, however concerns remain regarding the accuracy of results. Ordering absolute results more
Abstract BACKGROUND Craniosynostosis (CS), a structural anomaly characterized by premature fusion of cranial sutures, occurs in 1 in 2000 live births. Associations of CS with the thyroid have been reported. Neonatal thyroid hormone (T4) is evaluated nationally at birth by the Newborn Screening more
TechNavio's analysts forecast the Contract Research Organization market in the US to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing outsourcing of R&D activities. The Contract Research Organization market in the US more
TechNavio's analysts forecast the Global Contract Research Organization (CRO) market to grow at a CAGR of 10.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in outsourcing of R&D activities. The Global Contract Research Organization mark more
Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review Summary Charles River Laboratories International, Inc. (Charles River Laboratories) is a contract research organization (CRO), engaged in providing essential products and services for accelerating d more
Quintiles Clinical Commercial Consulting Capital Therapeutic Areas Careers Browse Information Library Start your search by selecting a topic or browse content in all topics Therapeutic Areas Business Needs Perspectives Services Locations Cardiovascular Central Nervous System (CNS) Diabetes more
Skip to content Management Team Board of Directors Scientific Advisors Clinical Advisors Contact Us Directions FLT3 Kinase AURORA Kinase BRAF Kinase Press Releases Events Visionary. Experienced. Savvy. Ambit Biosciences has raised approximately $105 million to date. In addition to our rounds of ve more
Quintiles Clinical Commercial Consulting Product Development & Commercialization Market Access Regulatory & Quality Consulting Market Intelligence Capital Therapeutic Areas Careers Browse Information Library Start your search by selecting a topic or browse content in all topics Therapeutic more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
